PVI
OCGN icon

Pura Vida Investments’s Ocugen OCGN Stock Holding History

Pura Vida Investments’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-225
Closed -$24K – 89
2017
Q2 		$24K Hold
225
– – 0.01% 68
2017
Q1 		$23K Hold
225
– – 0.01% 78
2016
Q4 		$23K Sell
225
-512
-69% -$71.1K 0.01% 67
2016
Q3 		$142K Buy
+737
New +$115K 0.04% 86

Other funds holding OCGN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Pura Vida Investments's OCGN Position: Q3 2017 in Review

Pura Vida Investments sold out of Ocugen (OCGN) in Q3 2017, closing a stake of 225 shares — an estimated $24K sold.

Pura Vida Investments first reported a position in OCGN in Q3 2016 and held it in 4 quarters. The position peaked at $142K in Q3 2016. 19 funds tracked by Wall St. Rank hold OCGN as of Q3 2017.

  • Pura Vida Investments reported no remaining Ocugen position as of Q3 2017 after selling out during the quarter.
  • Pura Vida Investments sold 225 Ocugen shares in Q3 2017, an estimated $24K.
  • Pura Vida Investments first reported a position in Ocugen in Q3 2016 and held it in 4 quarters.
  • Pura Vida Investments's Ocugen position peaked at $142K in Q3 2016.
  • 19 funds tracked by Wall St. Rank held Ocugen as of Q3 2017.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.